why choose us

First received: November 21, 2022

Clinical Trial: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Endometrial Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer

Brief Summary: This Phase II, global, single-arm study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial cancer.

Read more